# Weight Regain Rate After Stopping Semaglutide or Tirzepatide: 1.04 kg a Month

A Bayesian meta-analysis of 1,776 people who stopped semaglutide or tirzepatide found weight returning at 1.04 kg per month after an average 15.35 kg loss.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/weight-regain-a-kilogram-a-month
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Evidence

# Weight Regain Rate After Stopping Semaglutide or Tirzepatide: 1.04 kg a Month

A pooled analysis of 1,776 participants estimated 1.04 kg of weight regain per month after stopping semaglutide or tirzepatide. Follow-up lasted up to 52 weeks.

Editorial profile: [Neil Sanders](https://buythisglp.com/authors/neil-sanders)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20266 min readUpdated November 2026

Estimated average regain after stopping · 1.04 kg per month · 95% credible interval 0.80–1.29 kg per month · Observed follow-up 4–52 weeks

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   A Bayesian reanalysis used six studies, 10 treatment arms, and data from 1,776 participants.
-   The model estimated 15.35 kg of weight loss at cessation and 1.04 kg regained per month afterward.
-   Under a constant-rate model, the authors projected half the lost weight would return by 7.5 months and baseline weight by 15 months.
-   Follow-up lasted 4 to 52 weeks. The 15-month projection extends beyond the observed data.

## What the analysis measured

The authors used published group-level weight measurements from six studies of stopping semaglutide or tirzepatide. All six came from a previous systematic review. Their new model combined measurements from different follow-up visits to estimate an average rate across study arms.[\[1\]](https://buythisglp.com/research/weight-regain-a-kilogram-a-month#ref-1)

The estimated average weight loss at cessation was 15.35 kg (95% credible interval, 11.18 to 19.60 kg). The model estimated regain at 1.04 kg per month (95% credible interval, 0.80 to 1.29). For context on [how much weight people regain after stopping](https://buythisglp.com/research/how-much-weight-do-you-regain-after-stopping), individual withdrawal trials report changes at specific follow-up visits as well as group averages.[\[1\]](https://buythisglp.com/research/weight-regain-a-kilogram-a-month#ref-1)

## What the authors projected

Assuming regain continued at a constant rate, the authors projected that half the initial loss would return in 7.5 months (95% credible interval, 5.05 to 10.57 months). They projected a return to baseline in 15 months (95% credible interval, 10.10 to 21.13 months). The latter point estimate extends beyond the longest observed follow-up of 52 weeks.[\[1\]](https://buythisglp.com/research/weight-regain-a-kilogram-a-month#ref-1)

How to read the timelines

These projections describe the modeled average across study arms. The paper used group-level data, so the credible intervals describe uncertainty around the estimates and cannot predict the range of individual outcomes.[\[1\]](https://buythisglp.com/research/weight-regain-a-kilogram-a-month#ref-1)

## What comparisons remain uncertain?

After adjustment, the authors found no clear independent difference in regain rates between semaglutide and tirzepatide. They explored whether behavioral or lifestyle support was associated with slower regain, but the estimate was imprecise. Evidence about [continuing at a lower dose](https://buythisglp.com/research/can-you-lower-your-glp1-dose-to-maintain) comes from a different set of studies because the pooled analysis focused on people who stopped.[\[1\]](https://buythisglp.com/research/weight-regain-a-kilogram-a-month#ref-1)

If you are considering stopping, discuss follow-up and maintenance options with your prescriber. The study did not test how much weight any additional month of treatment would preserve for an individual.

## Frequently asked

How fast does the weight come back?

About 1.04 kg per month in this pooled analysis, with a 95% credible interval from 0.80 to 1.29, after an average loss of 15.35 kg at the point of stopping.

So how long until I am back where I started?

The authors projected about 15 months on average, assuming the regain rate stayed constant. The longest observed follow-up was 52 weeks, so this projection extends beyond the observed data.

Does everyone regain it?

The study estimated an average from group-level data. It does not establish whether or when any individual will regain all the weight they lost.

Does tapering help?

The analysis did not establish whether tapering slows regain. The estimate for behavioral or lifestyle support after stopping was uncertain.

## Sources

1.  \[1\] Kow CS, et al. (2026). Weight Regain Trajectories After Discontinuation of Semaglutide or Tirzepatide: A Reconstructed Aggregate-Data Bayesian Longitudinal Meta-Analysis Endocrinology, Diabetes & Metabolism. [PMID 42673571](https://pmc.ncbi.nlm.nih.gov/articles/PMC13529306/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
